
This study investigates pharmacodynamic responses to SGLT2 inhibitors and their genetic connections in a canagliflozin pilot study involving healthy volunteers. Acute changes in biomarkers are observed, with potential sex-related responses under data normalization. This approach aids genetic association discovery with reduced confounding factors in ongoing studies involving healthy individuals.
Like
Save
Share